Slowly expanding lesions are associated with disease activity and gray matter loss in relapse‐onset multiple sclerosis
Journal of Neuroimaging · 2024
DOI: 10.1111/jon.13243 ↗At a glance
Journal article in Journal of Neuroimaging, 2024. Written by Hiroaki Yokote and 8 co-authors. Institution: Department of Neurology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan. Major MEDLINE topics: Magnetic Resonance Imaging, Gray Matter, Disease Progression. Cited 7 times so far (Crossref); 44 references. Funded by: Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases), Ministry of Health, Labour, and Welfare of Japan, Scientific Research on Innovative Areas-Platforms for Advanced Technologies and Research Resources.
Abstract (original language)
Background and Purpose Slowly expanding lesions (SELs) have been proposed as novel MRI markers of chronic active lesions in multiple sclerosis (MS). However, the mechanism through which SELs affect brain volume loss in patients with MS remains unknown. Additionally, the prevalence and significance of SELs in Asian patients with MS remain unclear. This study aimed to investigate the association between SELs and no evidence of disease activity (NEDA)‐3 status as well as brain volume loss in Japanese patients.
Methods
A total of 99 patients with relapse‐onset MS were retrospectively evaluated. SELs were identified on brain MRI based on local deformation when consecutive scans were registered longitudinally. We developed a logistic regression model and generalized linear mixed models (GLMMs) to evaluate the association between the number of SELs and disease activity and changes in brain volume.
Results
During the observation period (2.0 ± 0.22 years), 35 patients developed at least one SEL. Multivariable logistic regression analysis showed that ≥2 SELs were associated with 0.2 times the risk of achieving a NEDA‐3 status. GLMMs revealed that the number of SELs was negatively associated with volume changes in the cortex ( p = .00169) and subcortical gray matter ( p = .00964) after correction for multiple comparisons.
Conclusion
SELs were identified in Japanese patients with MS during the 2‐year observation period. The number of SELs is associated with disease activity and brain volume loss, suggesting that the number of SELs could be a biomarker of disease activity in MS.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Neurology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
- Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan.
- Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.
- Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
- Department of Neurology, Nitobe Memorial Nakano General Hospital, Tokyo, Japan.
ORCID profiles: Hiroaki Yokote, Masaaki Niino
Funding
- Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases)
- Ministry of Health, Labour, and Welfare of Japan
- Scientific Research on Innovative Areas-Platforms for Advanced Technologies and Research Resources
- JSPS KAKENHI
- Grant-in-Aid for Scientific Research (C) JSPS KAKENHI
Cite
APA
Yokote, H., Miyazaki, Y., Fujimori, J., Nishida, Y., Toru, S., Niino, M., Nakashima, I., Miura, Y., & Yokota, T. (2024). Slowly expanding lesions are associated with disease activity and gray matter loss in relapse‐onset multiple sclerosis. Journal of Neuroimaging. https://doi.org/10.1111/jon.13243
Vancouver
Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, et al. Slowly expanding lesions are associated with disease activity and gray matter loss in relapse‐onset multiple sclerosis. Journal of Neuroimaging. 2024. doi:10.1111/jon.13243
BibTeX
@article{Yokote2024,
author = {Yokote, Hiroaki and Miyazaki, Yusei and Fujimori, Juichi and Nishida, Yoichiro and Toru, Shuta and Niino, Masaaki and Nakashima, Ichiro and Miura, Yoshiharu and Yokota, Takanori},
title = {Slowly expanding lesions are associated with disease activity and gray matter loss in relapse‐onset multiple sclerosis},
journal = {Journal of Neuroimaging},
year = {2024},
doi = {10.1111/jon.13243}
}
EUVIMED